-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_appendixes.pdf
March 01, 2009 - heart disease, stroke and transient ischemic attack, arrhythmias)
• Metabolic disorders (diabetes)
• Musculoskeletal … genitourinary cancers, cataracts, cataract surgery,
quality of life indicators, sexual function,
musculoskeletal … Endometrial cancer, uterine cancer, vaginal
bleeding/ spotting, musculoskeletal disorders.
-
effectivehealthcare.ahrq.gov/health-topics/fibromyalgia
-
effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-radiation-therapy-bone-metastases.pdf
August 01, 2022 - relief,
dependence on pain medication, need for further pain intervention, quality of life, rate of
musculoskeletal
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/obesity-in-adults-interventions
September 18, 2018 - Three trials demonstrated mixed results for musculoskeletal problems.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/75ftPGW4rZ-3tdMQPstvDg
August 01, 2012 - interventions included
increased fall-related outpatient visits after falls assessment,
self-reported musculoskeletal
-
hcup-us.ahrq.gov/reports/methods/2003_05.pdf
January 01, 2003 - years and older who
were not susceptible to falling† (PSI 8)
† That is, excluding patients with musculoskeletal
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/healthy-lifestyle-and-physical-activity-for-cvd-prevention-adults-without-known-risk-factors-behavioral-counseling
July 26, 2022 - between intervention participants and control groups on any adverse events, serious adverse events, musculoskeletal
-
hcup-us.ahrq.gov/reports/statbriefs/sb242-Pediatric-ED-Visits-2015.pdf
January 01, 2015 - Infectious and parasitic
diseases
Mental and behavioral
health conditions
Genitourinary disorders
Musculoskeletal
-
hcup-us.ahrq.gov/reports/statbriefs/sb205-Hospital-Discharge-Postacute-Care.pdf
November 01, 2015 - procedures discharged to PAC were distributed across five
different major diagnostic categories: two musculoskeletal
-
www.ahrq.gov/chsp/publications/index.html
September 01, 2023 - Association of Patient Engagement Strategies With Utilisation and Spending for Musculoskeletal Problems
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2006_MaskedStats_Core.PDF
January 01, 2006 - Frequency
Percent
of
Total
211: Other connective tissue disease 418411 1.61
212: Other bone disease and musculoskeletal
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2006v2_MaskedStats_Core.PDF
April 08, 2010 - Frequency
Percent
of
Total
211: Other connective tissue disease 412789 1.61
212: Other bone disease and musculoskeletal
-
hcup-us.ahrq.gov/reports/statbriefs/sb202-Mental-Substance-Use-Teenagers.pdf
November 01, 2015 - 34.1 5.3 1.7
Mental disorders 2 162,100 14.7 100.0 27.2
Digestive system 3 93,900 8.5 13.6 2.5
Musculoskeletal
-
digital.ahrq.gov/sites/default/files/docs/citation/r01hs025714%20-marcin-final-report-2023.pdf
January 01, 2023 - A standardized musculoskeletal clinical exam
was established and reviewed with therapists prior to the
-
hcup-us.ahrq.gov/reports/statbriefs/sb313-prevalence-burden-HAIs-2016-2021.pdf
January 01, 2021 - Diseases and disorders of the hepatobiliary system and pancreas
MDC 8 Diseases and disorders of the musculoskeletal
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/pskqLZMFcHjhtEF75uG4AP
January 01, 2012 - Screening for Osteoporosis: U.S. Preventive Services Task Force Recommendation Statement
Screening for Osteoporosis: U.S. Preventive Services Task Force
Recommendation Statement
U.S. Preventive Services Task Force*
Description: Update of the 2002 U.S. Preventive Services Task
Force (USPSTF) recommendation on screeni…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/e9f8a_uGMXxSbBUxpRPkrc
June 18, 2024 - The most common nonserious adverse events reported with
phentermine/topiramate were musculoskeletal and … study, the adverse effects that were slightly more
common with higher-dose phentermine/topiramate were
musculoskeletal
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction
September 03, 2019 - Symptomatic effects (eg, vasomotor, musculoskeletal) varied by medication. … All medications were associated with adverse effects, such as vasomotor or musculoskeletal symptoms,that
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing
August 20, 2019 - medications were associated with undesirable adverse effects for some women, such as vasomotor and musculoskeletal … All medications were associated with symptomatic adverse effects, such as vasomotor and musculoskeletal
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary27/breast-cancer-medications-for-risk-reduction-2013
April 15, 2013 - In STAR, raloxifene users reported more musculoskeletal problems, dyspareunia, and weight gain, whereas … serious adverse effects that impact quality of life and adherence, such as vasomotor, genital, and musculoskeletal